Efficacy of Serratus Posterior Intercostal Plane Block for Analgesia and Inflammatory Marker in Breast Surgery

ConditionsBreastcancer Perioperative Pain Inflammation

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age21-60

SponsorAin Shams University

About this trial

To study the efficiacy of serratus posterior superior block in controlling perioperative breast cancer surgery pain and its effect on inflamatory markers.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults undergoing unilateral breast surgery under general anesthesia

Age 21 to 60 years with body mass index (BMI)=18 to 25 kg/m2

American Society of Anesthesiologists (ASA) grade I-III.

Disqualifiers

Patients with Long-time use of analgesic drugs

Past history of chest surgery,

Allergy to local anesthetics,

Systemic infection,

Trial design

Design model

Parallel

Treatments tested in this trial

Analgesia mangement group A,B
Drug
1gm of paracetamol, 30mg of ketorolac and 1mg Granitryl will be given twenty minutes before the end of the operation .

Treatment groups

80 Participants

are divided into 2 treatment groups

Group A: will receive serratus posterior superior block using bupivacaineActive comparator 1 intervention

Group B: Arm B: (control group) patients will only receive general anesthesia without block.Other 1 intervention

Trial outcomes

Primary outcomes

is to calculate total perioperative analgesia consumption throughout (24hours).

Time frame

24 hour postoperative

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Ain Shams University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: